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Abstract: DNA methylation could be reversible and mouldable by environmental factors, such as
dietary exposures. The objective was to analyse whether an intervention with two Mediterranean
diets, one rich in extra-virgin olive oil (MedDiet + EVOO) and the other one in nuts (MedDiet + nuts),
was influencing the methylation status of peripheral white blood cells (PWBCs) genes. A subset
of 36 representative individuals were selected within the PREvención con DIeta MEDiterránea
(PREDIMED-Navarra) trial, with three intervention groups in high cardiovascular risk volunteers:
MedDiet + EVOO, MedDiet + nuts, and a low-fat control group. Methylation was assessed at
baseline and at five-year follow-up. Ingenuity pathway analysis showed routes with differentially
methylated CpG sites (CpGs) related to intermediate metabolism, diabetes, inflammation, and
signal transduction. Two CpGs were specifically selected: cg01081346–CPT1B/CHKB-CPT1B
and cg17071192–GNAS/GNASAS, being associated with intermediate metabolism. Furthermore,
cg01081346 was associated with PUFAs intake, showing a role for specific fatty acids on epigenetic
modulation. Specific components of MedDiet, particularly nuts and EVOO, were able to induce
methylation changes in several PWBCs genes. These changes may have potential benefits in
health; especially those changes in genes related to intermediate metabolism, diabetes, inflammation
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and signal transduction, which may contribute to explain the role of MedDiet and fat quality on
health outcomes.
Keywords: Mediterranean diet; DNA methylation; nuts; olive oil; blood cells
1. Introduction
Epigenetics has been defined as the study of heritable changes that cannot be explained through
variations in DNA nucleotide sequence [1], but can result in alteration of gene expression, providing
a connection among genetics, diseases, and the environment [2]. Actually, epigenetic alterations
have been associated to several diseases and complications, such as obesity, type 2 diabetes, adverse
cardiovascular events, or immune diseases [3]. Accumulating evidence suggests that epigenetic marks
are reversible [2,4] and they can be modulated by environmental factors [5,6]. Interestingly, nutrients
and specific dietary components of the diet are able to modify gene expression through changes in
DNA methylation [3]. Thus, the study of nutritional biomarkers and the progress in the epigenetics
field are contributing not only to define new nutrient roles in health and disease, but also to the
implementation of precision nutrition strategies [7].
Mediterranean diet (MedDiet) has been associated with a decrease in the risk of cardiovascular
events, with a favourable effect on blood pressure, insulin sensitivity, lipid profile, inflammation,
oxidative stress, and metabolic syndrome features [8–10]. Interestingly, MedDiet has been involved
in changes in DNA methylation. For instance, a preliminary study within the PREvención con DIeta
MEDiterránea (PREDIMED) trial reported associations between MedDiet and methylation at 1-year
in FTO (Alpha-ketoglutarate dependent dioxygenase) and TCF7L2 (Transcription factor 7 like 2)
genes [11]. Another ancillary study within PREDIMED-Navarra study described an association
between adherence to MedDiet and methylation of several inflammation-related genes in peripheral
white blood cells [12].
Although extra-virgin olive oil (EVOO) and nuts have been previously related to DNA
methylation changes [13,14], no new relationships between the different MedDiets (enriched in either
EVOO or nuts) from the PREDIMED trial and methylation have been described before. Therefore, the
aim of the current investigation was to explore methylation changes, which were caused by two diets
with Mediterranean profiles, in genes of peripheral white blood cells (PWBCs) from participants in the
PREDIMED-Navarra trial with emphasis on the impact of fat-quality.
2. Materials and Methods
2.1. Study Design and Participants
The current study was conducted within the framework of the PREDIMED trial. Briefly,
PREDIMED was a multicentre, randomized, primary prevention feeding trial with blinded assessment
of end points carried out in Spain with the aim of evaluating the effects of the MedDiet on primary
cardiovascular prevention (www.predimed.es). The study design has been described elsewhere [15,16],
and it was approved by the Research Ethics Committees at all of the recruiting centres in compliance
with the Helsinki Declaration. The Institutional Review Board of the Navarra recruitment centre
approved the study protocol (protocol 50/2005). All participants provided written informed consent.
This trial was registered with the International Standard Randomised Controlled Trial Number
system 35739639.
Eligible participants in PREDIMED trial were men aged 55–80 and women aged 60–80 years
without any previous history of cardiovascular disease. Inclusion and exclusion criteria have been
described elsewhere [15,16]. Participants were randomized to one of three nutrition interventions:
a MedDiet supplemented with EVOO (MedDiet + EVOO), a MedDiet supplemented with mixed nuts
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(MedDiet + nuts), or advice in reducing all sources of fat, which was the control group. All of the
groups received dietary training and questionnaires about medical conditions, food consumption
(such as 137-item validated food-frequency questionnaire) [17], and physical activity (Minnesota
Leisure-Time Physical Activity Questionnaire) [16] were completed as described elsewhere [15].
Data of anthropometric measures, body composition and blood pressure were collected in the same
consultations following standardized procedures [10]. Plasma, serum, and buffy-coat were stored
(−80 ◦C) and biochemical features were evaluated, as described elsewhere [10].
For this study, participants were selected from the recruitment centre at the University of Navarra
following different criteria: non-smokers or former-smokers, same proportion of women and men,
and aged between 60 and 70 years old, enrolling a total of 36 participants (12 from each diet) with data
at baseline and at five years of intervention.
2.2. DNA Extraction and DNA Methylation Analysis
The procedures for DNA extraction from buffy coat (PWBCs) of venous blood samples have
been described elsewhere [12]. The extracted DNA was sent on dry ice to Unidad de Genotipado y
Diagnóstico Genético from Fundación Investigación Clínico de Valencia, where bisulphite treatment
was performed and Infinium HumanMethylation450K bead chip (Illumina, San Diego, CA, USA) was
used for DNA methylation analysis as described elsewhere [12].
2.3. Treatment of Methylation Raw Data
Normalization of microarray data was performed in R by a categorical subset quantile
normalization method using the pipeline developed by Touleimat & Tost [18]. After data normalization,
Linear Models for Microarray Data (LIMMA) [19] was used to identify the probes with significant
differential methylation changes (five years–baseline) between two diets, being the comparisons:
MedDiet + EVOO vs. low-fat control diet and MedDiet + nuts vs. low-fat control diet. The linear
model was adjusted for age, sex, and microarray chip. The data discussed in this publication have been
deposited in NCBI’s Gene Expression Omnibus [20] and are accessible through GEO Series accession
number GSE107205 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE107205).
2.4. Ingenuity Pathway Analysis
From all the significant CpGs that were obtained after LIMMA analysis, a selection was carried
out in order to have an appropriate number of CpGs for obtaining relevant results in the analysis
of canonical pathways by Ingenuity Pathway Analysis (IPA) platform (Qiagen Redwood City, CA,
USA, www.ingenuity.com). CpGs with a p < 0.005 and effect size ≤−9 or ≥9 (the effect size represents
the methylation change for the CpG site in %) were selected. Predefined pathways and functional
categories of the Ingenuity Knowledge Base were used in order to detect associated pathways and
relevant gene regulatory networks [21]. Canonical pathways with a p < 0.05 after Fisher’s test were
defined as a statistically significant overrepresentation of input genes in a given process.
2.5. Differential CpG Site Selection
In order to select CpGs presenting a higher effect on methylation with biological implications
that could be noticeable and minimize the type I error rate, a series of statistically restricted selections
with stringent criteria were performed. CpG sites were selected by B-values (statistic of differential
methylation generated in LIMMA package) >0 and effect size ≤−9 or ≥9 for both of the comparisons.
Moreover, methylation values must not be significantly different among the three dietary groups at
baseline, but show differences throughout the intervention. The tests that were used in these cases
were ANOVA with Tukey’s multiple comparison test or Kruskal-Wallis with Mann-Whitney’s U
test, when appropriate, and Student-t test or sign test, when appropriate. Then, regression models
between selected CpGs methylation and foods or their components, adjusted for diabetes and BMI,
were performed.
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2.6. Blood Cell Type Composition
Differences in the composition of types of leukocytes between five years and baseline were
correlated (Pearson) with nuts intake at five years, EVOO consumption at five years and with
methylation of the CpGs selected. Differences among dietary groups in the composition of blood cells
were also assessed.
2.7. Statistical Analysis of Participants
Anthropometric and biochemical features of participants and food consumption were
characterised and tested comparing the three groups at baseline, at five years and their differences
(five years-baseline) using ANOVA or Kruskal-Wallis test (for quantitative variables) and Chi-square
test, Fisher’s exact test, or Cochran test (for qualitative variables), as appropriate. The values were also
compared for each diet between five years and baseline using Student t-test, Wilcoxon signed-rank
test, Sign test, or Cochran test, when advised. The Shapiro-Wilk analysis was used to test normality.
Statistical calculations and graphs were performed using STATA version 12.0 (Stata Corp, College
Station, TX, USA) and GraphPad Prism 6 (Graph-Pad Software, San Diego, CA, USA), respectively.
The statistically significant level was set at p < 0.05.
3. Results
3.1. Participants’ Differences in Anthropometric and Biochemical Features, Food Consumption and Blood Cell
Type Composition
The three dietary groups showed no differences in anthropometric and biochemical features,
except for HDL cholesterol levels measured at five years. Concerning clinical manifestations, the three
groups exhibited a significant decrease in diabetes, hypercholesterolemia, and arterial hypertension
cases after five years of intervention, except for diabetes in low-fat control diet and for arterial
hypertension in MedDiet + nuts group, which did not present significant differences (Table 1).
Energy and nutrient intakes were also recorded (Table 2). At the baseline, no significant differences
between groups were noted. The highest significant differences were observed for nuts and EVOO
consumption at five years among the three groups. Moreover, EVOO consumption was statistically
different between five years and baseline in MedDiet + EVOO group. Some differences were also
observed in fruit intake between five years and baseline in low-fat control diet and MedDiet + nuts
group, as well as in red meat intake in MedDiet + EVOO group. There were also differences in legumes
intake between five years and baseline in MedDiet + nuts group and among the three groups.
Since methylation measured in PWBCs can vary by blood cell type, and thus the methylation
changes that are associated with the variables investigated in this study may reflect an alteration
in blood cell composition, correlation studies were performed between the relative proportions of
granulocytes, lymphocytes, or mid cells and nuts intake, EVOO intake or methylation of the selected
CpGs, but no associations for any comparison were found (Supplementary Materials Table S1). There
were also no differences in blood cell types among the three dietary groups (Supplementary Materials
Table S2).
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Table 1. Anthropometric, clinical and biochemical characteristics of the study population, with the statistical differences among the three dietary groups at baseline
and after five-year follow-up.
Low-Fat Control Diet (n = 12)
p2
MedDiet + EVOO (n = 12)
p2
MedDiet + nuts (n = 12)
Baseline 5 Years Baseline 5 Years Baseline 5 Years p2 p 03 p 53 p ∆3
Female, n (%) 6 (50) 6 (50) 6 (50) ns
Age(years) 1 64.3 (3.9) NA 63.5 (1.7) NA 63.2 (2.1) NA ns
Weight(kg) 1 73.0 (10.9) 73.1 (9.6) ns 73.3 (9.4) 74.6 (10.7) ns 71.6 (7.5) 73.2 (7.6) ns ns ns ns
Waist circumference(cm) 1 92.4 (9.6) 92.4 (9.5) ns 90.1 (7.1) 93.8 (6.4) ns 93.5 (6.3) 94.3 (6.7) ns ns ns ns
BMI(kg/m2) 1 27.3 (3.2) 27.4 (2.9) ns 27.9 (1.5) 28.3 (1.8) ns 28.1 (1.5) 28.8 (1.8) ns ns ns ns
Glycemia(mg/dL) 1 106.0 (27.6) 102.2 (18.0) ns 129.5 (67.1) 120.8 (52.7) ns 131.5 (57.4) 127.0 (34.9) ns ns ns ns
HDL cholesterol(mg/dL) 1 52.7 (14.5) 51.5 (13.3) ns 55.2 (8.3) 55.1 (10.4) ns 60.9 (9.1) 64.6 (12.0) ns ns 0.022 ns
LDL cholesterol(mg/dL) 1 132.0 (15.5) 112.3 (27.1) ns 122.0 (30.5) 113.0 (26.3) ns 119.1 (23.2) 123.1 (35.2) ns ns ns ns
Total cholesterol(mg/dL) 1 209.8 (21.0) 188.6 (27.7) ns 203.4 (28.7) 191.6 (29.1) ns 199.2 (24.3) 210.4 (41.2) ns ns ns ns
Triglycerides(mg/dL) 1 126.1 (49.6) 124.1 (40.7) ns 131.2 (78.2) 117.6 (47.9) ns 95.7 (24.6) 113.4 (40.0) ns ns ns ns
Systolic arterialpressure (mmHg) 1 148.9 (17.2) 150.1 (22.4) ns 158.5 (19.1) 157.6 (20.5) ns 142.9 (16.0) 147.7 (21.6) ns ns ns ns
Diastolic arterialpressure (mmHg) 1 85.7 (8.6) 85.8 (11.4) ns 88.1 (8.4) 83.9 (10.0) ns 87.9 (7.2) 87.2 (14.0) ns ns ns ns
Diabetes, n (%) 1 (8) 0 (0) ns 4 (33) 0 (0) 0.046 6 (50) 0 (0) 0.014 ns ns 0.022
Hypercholesterolemia, n (%) 8 (67) 0 (0) 0.005 9 (75) 1 (8) 0.005 10 (83) 1 (8) 0.003 ns ns ns
Arterial hypertension, n (%) 12 (100) 0 (0) <0.001 11 (92) 1 (8) 0.004 10 (83) 4 (33) ns ns ns 0.010
Hypertriglyceridemia, n (%) 1 (8) 2 (17) ns 2 (17) 0 (0) ns 0 (0) 0 (0) ns ns ns ns
1 Values are represented as Mean (SD).2 Values obtained by Student t-test, Wilcoxon signed-rank test, Sign test or Cochran test, as appropriate, comparing data from 5 years and baseline
for each diet.3 Values obtained by chi-square test, Fisher’s exact test or Cochran test (for qualitative variables), and ANOVA test or Kruskal-Wallis test (for quantitative variables),
as appropriate, from baseline data (p 0), from five years data (p 5) or from the difference between 5 years and baseline data (p ∆) among the three groups. p < 0.05 is considered significant.
EVOO: extra-virgin olive oil; HDL: high-density lipoprotein; LDL: low-density lipoprotein; MedDiet: Mediterranean diet; NA: non-applicable; ns: non-significant.
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Table 2. Energy and nutrient intake of participants and statistical differences among the three dietary groups at baseline and after five-year follow-up.
Low-Fat Control Diet (n = 12)
p2
MedDiet + EVOO (n = 12)
p2
MedDiet + nuts (n = 12)
p2 p 03 p 53 p ∆3
Food/component (g/day) Baseline 5 Years Baseline 5 Years Baseline 5 Years
Carbohydrates 230.4 (46.7) 267.9 (60.1) ns 239.4 (82.1) 248.7 (76.2) ns 224.9 (52.3) 240.8 (44.9) ns ns ns ns
Proteins 89.9 (23.9) 96.8 (16.1) ns 88.9 (16.0) 88.7 (14.8) ns 91.5 (16.0) 95.0 (18.9) ns ns ns ns
Fat 100.5 (24.2) 97.2 (19.5) ns 108.2 (30.3) 117.3 (25.6) ns 108.9 (19.4) 124.1 (25.1) ns ns 0.017 ns
MUFA 51.8 (11.8) 51.3 (11.0) ns 56.6 (16.4) 63.9 (10.6) ns 55.3 (12.4) 64.6 (13.0) ns ns 0.014 ns
SFA 23.3 (7.2) 22.5 (7.3) ns 26.7 (8.9) 25.0 (6.8) ns 24.8 (5.3) 28.8 (8.1) ns ns ns ns
PU FA 15.8 (5.5) 15.5 (5.0) ns 16.8 (6.3) 16.9 (4.2) ns 18.6 (4.7) 19.7 (4.1) ns ns ns ns
Vegetables 302.1 (90.2) 352.2 (104.2) ns 302.3 (117.8) 370.2 (58.2) ns 298.9 (71.1) 372.7 (129.1) ns ns ns ns
Fish 73.5 (32.6) 93.6 (37.5) ns 90.2 (33.8) 82.6 (25.7) ns 91.2 (33.5) 100.4 (39.9) ns ns ns ns
Fruits 291.6 (145.1) 431.4 (237.1) 0.009 319.8 (181.9) 459.3 (109.9) ns 367.2 (163.2) 500.8 (186.7) 0.034 ns ns ns
Legumes 17.9 (9.9) 14.7 (6.4) ns 16.0 (4.7) 19.6 (7.5) ns 15.5 (3.5) 20.4 (5.8) 0.019 ns ns 0.034
Nuts 12.2 (18.2) 5.5 (8.8) ns 9.9 (16.4) 11.3 (8.3) ns 20.5 (15.1) 28.2 (14.2) ns ns <0.001 ns
EVOO 29.6 (26.3) 32.9 (26.2) ns 39.6 (24.7) 66.4 (8.1) 0.003 25.0 (30.0) 33.8 (32.4) ns ns 0.002 0.049
Rest of olive oils 16.7 (24.6) 16.7 (24.6) ns 10.0 (15.8) 0 (0) 0.049 26.3 (27.6) 25.8 (32.6) ns ns ns ns
Red meat 63.2 (42.5) 59.8 (38.1) ns 71.7 (42.3) 39.5 (28.0) 0.045 57.5 (29.8) 54.8 (32.6) ns ns ns ns
White meat 54.9 (28.6) 63.0 (25.4) ns 39.5 (22.4) 36.7 (26.8) ns 43.1 (23.2) 47.7 (26.4) ns ns ns ns
Pastries 35.3 (18.2) 36.9 (27.3) ns 43.4 (24.5) 29.8 (21.4) ns 23.9 (21.1) 37.6 (27.6) ns ns ns ns
Total energy (kcal/day) 2310 (420) 2412 (475) ns 2378 (651) 2470 (513) ns 2349 (432) 2535 (452) ns ns ns ns
Values are represented as Mean (SD).1 Values obtained by Student t-test, Wilcoxon signed-rank test or Sign test, as appropriate, comparing data from 5 years and baseline for each diet.2
Values obtained by ANOVA test or Kruskal-Wallis test, as appropriate, from baseline data (p 0), from 5 years data (p 5) or from the difference between 5 years and baseline data (p ∆)
among the three groups. p < 0.05 is considered significant. EVOO: extra-virgin olive oil; MedDiet: Mediterranean diet; ns: non-significant; MUFA: monounsaturated fatty acids; PUFA:
polyunsaturated fatty acids; SFA: saturated fatty acids.
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3.2. Relevant Differentially Methylated CpGs Were Related to Metabolism, Inflammation, Intracellular Signals
and Diabetes
For IPA analysis, 223 CpGs from MedDiet + EVOO vs. low-fat control diet comparison and
359 CpGs from MedDiet + nuts vs. low-fat control diet were analysed. The obtained canonical
pathways were collected for both comparisons (Supplementary Materials Table S3 and Table S4,
respectively). Some CpGs from both of the comparisons were related to metabolism, such as Fatty
Acid Activation, γ-linolenate Biosynthesis II, Fatty Acid β-oxidation I, Fatty Acid α-oxidation, and
Adipogenesis pathway. CpGs from MedDiet + EVOO vs. low-fat control diet comparison were related
to pathways that were involved in inflammation, such as Leukocyte extravasation signaling, LPS/IL-1
Mediated Inhibition of retinoid acid receptor function, and Crosstalk between Dendritic Cells and
Natural Killer Cells. On the other hand, CpGs from MedDiet + nuts vs. low-fat control diet comparison
were related to a variety of intracellular signals (apoptosis and DNA damage, Protein kinase A, Notch,
G-Protein coupled receptor, Stress-activated protein kinase/c-Jun NH(2)-terminal kinase, etc.), and
with diabetes (Type II Diabetes Mellitus Signalling).
3.3. Two Differentially Methylated CpGs (cg01081346 and cg17071192) Were Selected
After those preliminary analyses, CpGs were selected by B-values >0 and effect size ≤ −9 or ≥ 9
for both comparisons, as well as by showing non-significant differences in methylation values among
the three dietary groups at baseline and showing significant differences throughout the intervention.
Two CpGs were obtained: cg01081346 and cg17071192. The CpG cg01081346 presented an increase
in methylation in MedDiet + nuts after five years of intervention (Figure 1a), and showed significant
higher methylation changes in MedDiet + nuts subjects when comparing with the other two dietary
groups (Figure 1b). In addition, nuts intake (g/day) at five years of follow-up was associated
with an increase in cg01081346 methylation (Figure 1c). The other CpG (cg17071192) presented
a methylation decrease in MedDiet + EVOO throughout the intervention (Figure 2a) and showed
significant differences in methylation changes between the MedDiet + EVOO group and the other
two groups (Figure 2b). The corresponding genes for these CpGs, according to the Illumina CG
database, were CPT1B/CHKB-CPT1B (Carnitine palmitoyltransferase 1B/Choline kinase-like, Carnitine
palmitoyltransferase 1B) for cg01081346, located at the TSS220, TSS1500 (CPT1B) and body of the
gene (CHKB-CPT1B), and GNAS/GNASAS (Guanine Nucleotide Binding Protein (G Protein), Alpha
Stimulating Activity Polypeptide 1/GNAS Antisense RNA 1) for cg17071192, located at the body of
the gene (GNASAS) and TSS1500 (GNAS).
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Figure 1. Representation of significant methylation changes of cg01081346. (a) Methylation mean and
SD of each dietary group at baseline and at 5 years. Statistical analysis was performed by a Student-t test
between 5 y ars and baseline for each diet. (b) M hylation c anges (Me and SD) for each participant
and diet. S atistical analys of differences in methylation changes mong diets w s performed by
ANOVA (+Tukey’s multiple comparison test). Significance is considered * p < 0.05, *** p < .001.
(c) Regression graph representing th relation b tween methylation changes a d nuts intake at 5 years.
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Figure 2. Representation of significant methylation changes of cg17071192. (a) Methylation mean
and SD of each dietary group at baseline and at 5 years. Statistical analysis was performed by a
Student-t test between 5 years and baseline for each diet. (b) Methylation changes (Mean and SD) for
each participant and diet. Statistical analysis of differences in methylation changes among diets was
performed by ANOVA (+Tukey’s multiple comparison test) or Kruskal-Wallis (+Mann-Whitney’s U),
when appropriate. Significance is considered * p < 0.05, ** p < 0.01. EVOO: extra-virgin olive oil;
MedDiet: Mediterranean diet.
3.4. CpG cg01081346 Was Associated with PUFAs
In order to check whether fatty acids were related to methylation changes, other regression
analyses were performed between methylation changes of CpGs and total lipids, saturated fatty acids,
monounsaturated fatty acids (MUFAs), and polyunsaturated fatty acids (PUFAs) that were consumed
at five years. Results showed that methylation of cg01081346 was associated with PUFAs (Figure 3),
whereas cg17071192 presented no association.
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4. Discussion
The current study de onstrates that a edDiet pattern plus specific food supple ents rich in
different fat quality, in this case nuts and EVOO, could induce changes in methylation levels i pe ific
CpGs of PWBCs. Therefore, further insights are added to previous reports wh re environm ntal
factors, including the diet, were abl to modify the ep enome [22].
edDie s supple ente with nuts or EVOO have evidenced ben ficial effects in individuals
with cardiovascular risk [8]. A ong these effects, decreased levels of LDL cho esterol a d increased
levels of HDL cholesterol were observed [23]. In the subs t of participants selected for this study, there
w r differences among the thre groups in HDL cholesterol. In fact, the low-fat dietary c n rol group
decreased HDL levels, whereas M dDiet + EVOO maintained th levels and M dDiet + nuts increased
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them. In most cases, there was a reduction in the incidence of diabetes, hypercholesterolemia and
arterial pressure, indicating a general improvement in health status after each dietary intervention.
Regarding MedDiet supplements intake, although MedDiet + EVOO group presented differences
in consumption of EVOO at five years and in changes between five years and baseline, MedDiet +
nuts only showed differences in nuts intake at five years. This result could be influenced by the initial
values of nuts consumption of the MedDiet + nuts group, which were higher than in the other two
groups, although not statistically significant. Some dietary groups presented differences in other foods
intake, probably due to dietary advice.
The IPA strategy revealed that the selected differentially methylated genes were mainly related to
intermediate metabolism, inflammation, intracellular signals, and diabetes phenomena. These areas
are interconnected and MedDiets supplemented with EVOO or nuts have been described as having a
favourable impact in different features related to them, such as inflammatory parameters, hypertension,
hyperlipidaemia, among others [8,9]. Thus, MedDiet, and especially the food supplements employed,
EVOO and nuts, could be inducing changes in the DNA methylation, which in turn, may cause
changes in the expression of some genes that are associated with these processes and related diseases.
For instance, Rodríguez-Miguel et al. showed that an olive oil-enriched diet increased levels of global
methylation in mammary glands and tumours [13]. In addition, adherence to MedDiet has been
associated with changes in methylation in inflammatory-related genes in a previous study from this
group [12]. Further studies of the relationship between significant genes and the pathways from IPA
would be interesting to elucidate their putative involvement in MedDiet health beneficial effects.
After an exhaustive analytical selection in order to choose the most relevant CpGs that had
diet-induced methylation changes, two CpGs were specifically analysed: cg01081346–CPT1B/
CHKB-CPT1B and cg17071192-GNAS/GNASAS. Interestingly, three surrounding CpGs of 27 for
CPT1B/CHKB-CPT1B and 13 CpGs of 129 for GNAS/GNASAS also showed significant differences
(p < 0.05). These CpGs may be related to the expression of genes performing actions that were in
agreement with the differentially methylated areas obtained in the IPA. For instance, CPT1B has
been related to insulin sensitivity and cardiac risk [24,25]. This gene is implicated in the conversion
of acyl-CoA and carnitine into acyl-carnitine in the outer membrane of mitochondria, determining
the balance between glucose and fatty acid metabolism [26]. The levels of these molecules are very
important in lymphocytes and mononuclear phagocytes metabolism [27]. On the other hand, GNASAS
encodes for an antisense RNA transcript that regulates GNAS, which has been involved in glucose
and energy regulation [28,29]. Although methylation levels were measured in PWBCs, which are not
very related to some of the aforementioned functions, these cells could be proxies for less accessible
tissues [30]. Indeed, differentially methylated CpGs in blood cells have been identified as mirroring
the adipose tissue methylation pattern [31].
Nuts and EVOO are both rich in MUFAs and PUFAs [32,33]. In fact, in this study, methylation
of CpG cg01081346 was associated with PUFA uptake. It is likely that this CpGs could be influenced
by fat quality due to PUFAs consumed in nuts. Indeed, it has been described that the quality of
dietary fat influences the methylation of genes [34]. Nevertheless, the CpG cg17071192 might change
the methylation pattern due to other MedDiet nutrients or other compounds that are present in
EVOO. For instance, polyphenols from EVOO have been described down-regulating proatherogenic
genes [35], while some derivatives (hydroxityrosol, tyrosol, and their secoiridoid derivatives) have
shown strong antioxidant and anti-inflammatory activity in vitro [36,37]. In addition, the stimulatory
effect of phenolic extracts from EVOO and hydroxityrosol on cannabinoid receptor 1 (CB1) expression
inversely correlated with DNA methylation at cannabinoid receptor 1 promoter and it was associated
with reduced proliferation of human colon cancer cells [38].
The present investigation was not devoid of limitations. Firstly, the sample size is relatively low,
but the results are plausible. Secondly, mRNA levels could be evaluated in order to determine EVOO
and nuts roles on the modification of the methylation levels and in turn, the effect on the expression of
genes with a function in the maintenance of a good health status.
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5. Conclusions
Summing up, this study shows that an intervention with MedDiet + EVOO and MedDiet + nuts
in the PREDIMED-Navarra trial are influencing the methylation of genes in PWBCs. This effect might
be, in part, due to the fat profile of either EVOO or nuts. Specifically, methylation changes occurs in
genes related to intermediate metabolism, diabetes, inflammation, and signal transduction process,
such as CPT1B and GNAS, which are specifically involved in acyl-carnitine process in mitochondria,
and glucose and energy regulation, respectively. Hence, the potential beneficial effects on health of
Mediterranean dietary pattern supplemented with EVOO or nuts could be mediated, at least in part,
through epigenetic mechanisms, where the quality of fat intake, such as PUFA consumption, is playing
a mediating role.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/10/1/15/s1,
Table S1: Pearson correlation values of differences in types of leukocytes and consumption at 5 years of extra-virgin
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dietary groups in the composition of blood cells, Table S3: Canonical pathways (Ingenuity Pathway Analysis)
associated with differentially methylated CpGs selected from MedDiet + EVOO vs. low-fat control diet LIMMA
analysis, Table S4: Canonical pathways (Ingenuity Pathway Analysis) associated with differentially methylated
CpGs selected from MedDiet + nuts vs. low-fat control diet LIMMA analysis.
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